Monoallergen Sublingual Immunotherapy Versus Multiallergen Subcutaneous Immunotherapy for Allergic Respiratory Diseases: A Debate During the AAAAI 2013 Annual Meeting in San Antonio, Texas

Article ID	Journal	Published Year	Pages	File Type
3204369	The Journal of Allergy and Clinical Immunology: In Practice	2014	8 Pages	PDF

Keywords

FDA RCT Sublingual allergen immunotherapy HDM SCIT SMD SLIT DBPC AIT Allergic asthma US Food and Drug Administration Allergen immunotherapy subcutaneous allergen immunotherapy standardized mean difference double-blind, placebo-controlled Allergic rhinitis Index of reactivity Randomized Clinical Trial House dust mite

Related Topics

Life Sciences Immunology and Microbiology Immunology

Monoallergen Sublingual Immunotherapy Versus Multiallergen Subcutaneous Immunotherapy for Allergic Respiratory Diseases: A Debate During the AAAAI 2013 Annual Meeting in San Antonio, Texas

Authors

Moises A. MD, PhD, Linda S. MD,